DD Support Board and Research Team

[236T568]

How is that SLAPP success rate going?


http://www.citronresearch.com/stocklemon-reports-on-hemispherx-biopharma-amex-heb/

Motley Fool writer Bill Mann said it best about Hemispherx when he wrote,” There are a few companies I follow simply because I can not believe that people invest in them.” There is nothing that Stocklemon can write that has not been established by famed short seller Manuel Asensio in his many reports on Hemispherx Biopharma that date back to 1998. Hemispherx went as far as to sue Asensio in a Philadelphia court, a case which Hemispherx lost in February of 2002.

http://www.asensio.com/HemispherxBiopharma/HebIndex.htm

Please check your facts before posting false info that may be detrimental to shareholders' interests. I am large shareholder of HEB and an attorney, and I am not afraid to pursue legal recourse against those spreading false information about this company.